1. Academic Validation
  2. Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy

Hydroxytyrosol-Derived Compounds: A Basis for the Creation of New Pharmacological Agents for Cancer Prevention and Therapy

  • J Med Chem. 2015 Dec 10;58(23):9089-107. doi: 10.1021/acs.jmedchem.5b00669.
Roberta Bernini 1 Maria Saveria Gilardini Montani 2 Nicolò Merendino 3 Annalisa Romani 4 Francesca Velotti 3
Affiliations

Affiliations

  • 1 Department of Agriculture, Nature, Forests and Energy (DAFNE), Tuscia University , Via S. Camillo De Lellis, 01100 Viterbo, Italy.
  • 2 Department of Experimental Medicine, Sapienza University of Rome , 00161 Rome, Italy.
  • 3 Department of Ecological and Biological Sciences (DEB), Tuscia University , 01100 Viterbo, Italy.
  • 4 PHYTOLAB (Pharmaceutical, Cosmetic, Food Supplement Technology and Analysis)-DISIA, University of Florence , 50134 Florence, Italy.
Abstract

Hydroxytyrosol [2-(3,4-dihydroxyphenyl)ethanol, HTyr] is a phenolic compound found in olive leaves and fruits and extra-virgin olive oil, which has well-known strong antioxidant and radical-scavenging properties. Recently, it has received particular attention for its antiproliferative and apoptotic activities and its anti-inflammatory properties. During the past few years, more efforts have been focused on synthesizing HTyr-derived compounds with enhanced biological activities for their potential use in different chronic degenerative diseases. In this paper, we report a dissertation on the current knowledge of selected synthetic HTyr derivatives and analogues and their potential use in Cancer prevention and therapy, which are related to their antioxidant, antiproliferative/apoptotic, and anti-inflammatory properties. On the basis of the perspective of using HTyr-derived compounds as Anticancer agents, we have taken into account only studies that were performed in experimental cell-based models.

Figures